Bartosz Wasag, Els Lierman, Peter Meeus, Jan Cools and Peter Vandenberghe (2011) “The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11)”, Haematologica. Pavia, Italy, 96(6), pp. 922-926. doi: 10.3324/haematol.2010.036558.